Nigeria’s ‘Malaria-Typhoid’ Habit Is Fueling Resistance
A familiar Nigerian scene: someone wakes up with fever, body aches, headache and weakness. By evening, a neighbour has recommended “malaria and typhoid drugs.” A pharmacy attendant offers antimalarials, antibiotics and painkillers in one plastic bag. No test. No prescription. No follow-up. If the fever goes down, the treatment is declared a success. If it returns, the dose is repeated or upgraded.
This habit feels practical in a country where clinics can be costly, queues are long and malaria is genuinely common. But the “malaria-typhoid” shortcut is becoming a public health problem Nigerians can no longer afford to ignore. It encourages misdiagnosis, wastes household money and pushes antibiotics closer to failure.
Malaria is not always typhoid. Fever is not a diagnosis. And antibiotics are not harmless backup drugs.
The fever trap: why malaria and typhoid get lumped together
Malaria and typhoid fever can look similar at the start: fever, headache, weakness, stomach discomfort, vomiting or body pain. In everyday conversation, they have almost merged into one illness: “malaria-typhoid.” That phrase is now so common that many people treat it as a standard medical condition.
But malaria is caused by parasites transmitted by infected mosquitoes. Typhoid fever is caused by Salmonella Typhi, a bacterium usually spread through contaminated food or water. The treatments are completely different. Malaria requires effective antimalarial therapy after proper diagnosis. Typhoid, when confirmed or strongly suspected, requires the right antibiotic at the right dose for the right duration.
The danger starts when symptoms are treated as proof. A person with dengue, COVID-19, urinary tract infection, pneumonia, viral hepatitis, meningitis or even severe dehydration may be treated repeatedly for “malaria-typhoid” while the real condition worsens.
Nigeria’s malaria burden is high, so suspicion is understandable. But high burden does not mean every fever is malaria. The World Health Organization has long pushed for parasitological confirmation of suspected malaria where possible, using microscopy or rapid diagnostic tests. A malaria test is not perfect, but it is better than guessing, especially when antibiotics are being added “just in case.”
The Widal problem and the illusion of certainty
A major reason typhoid is overdiagnosed in Nigeria is the misuse of the Widal test. Many patients walk into laboratories, request “malaria and typhoid test,” and leave with a result that appears to confirm typhoid. The problem is that Widal results are often difficult to interpret, especially in places where exposure to related bacteria is common, vaccination history is unclear, and laboratories use different cut-offs.
A positive Widal test does not automatically mean a person currently has typhoid fever. In many settings, blood culture remains the more reliable diagnostic method, though it is slower, more expensive and less available. Because of this gap, patients are often told they have typhoid based on weak evidence, then given antibiotics they may not need.
Consider a student in Ibadan with fever during exam week. A quick test says malaria “one plus” and Widal “positive.” She buys artemisinin-based combination therapy, ciprofloxacin or azithromycin, paracetamol and multivitamins. Her symptoms improve after two days because many fevers improve naturally or because the antimalarial worked. She never knows whether she had typhoid. The antibiotic course is stopped halfway when she feels better. The leftover tablets are saved for a roommate.
Multiply that by millions of similar decisions across homes, campuses, bus parks, offices and markets. That is how misuse becomes normal.
Antibiotic resistance is not an abstract future threat
Antibiotic resistance happens when bacteria evolve ways to survive drugs that once killed them. Misuse accelerates the process: taking antibiotics without need, using the wrong drug, under-dosing, stopping early, sharing leftovers or buying incomplete courses.
For typhoid, this matters urgently. Strains of Salmonella Typhi resistant to older antibiotics have spread in many countries. In some places, extensively drug-resistant typhoid has limited treatment options and forced doctors to rely on more expensive or less accessible medicines. The more casually antibiotics are used, the faster these options shrink.
Nigeria’s problem is not simply that people make “bad choices.” The system pushes them there. Many patients pay out of pocket. A clinic visit, lab test, transport fare and prescribed medicines can consume a large share of weekly income. Community pharmacies and patent medicine shops are often the first point of care. Some are careful and professional; others sell antibiotics over the counter because demand is high and enforcement is weak.
There is also a trust issue. If a patient has previously paid for tests and still felt poorly, they may decide next time to self-treat. If a doctor once prescribed antibiotics with antimalarials for fever, the patient may assume that combination is standard. If a lab result is presented without explanation, the patient may treat numbers rather than illness.
Antibiotic resistance turns these individual shortcuts into collective harm. When common drugs stop working, everyone pays: longer illnesses, more hospital admissions, higher treatment costs, greater risk in childbirth and surgery, and more deaths from infections that were once manageable.
The household cost of guessing wrong
Self-treatment is often defended as cheaper. Sometimes it looks that way at the counter. But the full cost can be much higher.
A family may spend ₦5,000 to ₦20,000 on antimalarials, antibiotics, painkillers and “blood tonic” for a fever that needed only a malaria test and targeted treatment—or no antibiotic at all. If symptoms persist, they spend again at another pharmacy. By the time they reach a clinic, the illness may be more severe, and the doctor now has to manage both the original disease and the effects of delayed care.
There are hidden costs too: missed workdays, transport, repeated lab tests, school absence, borrowing money, and the emotional cost of watching a child remain ill after several rounds of “strong drugs.” For low-income households, this cycle is financially punishing.
Misdiagnosis also distorts public health data. If every fever becomes “malaria and typhoid,” health authorities get a blurrier picture of what is actually circulating. Outbreaks can be missed. Environmental sources of typhoid—contaminated water, poor sanitation, unsafe food handling—may go uninvestigated because cases are scattered across private treatment decisions and informal drug sales.
What should change now
The solution is not to shame sick people. It is to make the safer choice easier.
First, fever should be tested before treatment whenever possible. Rapid malaria tests are widely available and can prevent unnecessary antimalarial use. Typhoid diagnosis needs more caution: clinicians should interpret symptoms, exposure history and test results together rather than treating Widal results as automatic proof.
Second, antibiotics should be prescription-only in practice, not just on paper. Pharmacies and patent medicine vendors need clearer rules, routine inspection and support to refer patients with persistent fever, blood in stool, severe weakness, confusion, pregnancy, infants, elderly patients or signs of dehydration.
Third, clinicians must also audit their own habits. If antibiotics are prescribed “just in case” for uncomplicated fever, patients learn that this is normal. Clear communication matters: “Your malaria test is positive; you do not need antibiotics today” is a public health intervention.
Fourth, households need a new fever rule: test, treat correctly, and return if symptoms persist. Do not share antibiotics. Do not stop prescribed antibiotics early. Do not keep leftovers for the next illness. And do not treat typhoid because a neighbour had similar symptoms.
Finally, Nigeria must invest in water, sanitation and vaccination where appropriate. Typhoid is not only a clinic problem; it is an infrastructure problem. Cleaner water and safer food reduce the need for antibiotics in the first place.
Conclusion
The phrase “malaria-typhoid” may sound harmless, but the behaviour behind it is costly. It encourages Nigerians to guess their way through fever, buy antibiotics they may not need and delay proper care when the illness is something else.
Malaria is common. Typhoid is real. But they are not a single disease, and treating them as one is helping antibiotic resistance gain ground. The smarter response to fever is not a bigger drug cocktail. It is better diagnosis, disciplined antibiotic use and a health system that makes doing the right thing affordable.